Want to join the conversation?
$LYB posted 3Q15 earnings of $1.2Bil, or $2.55 per share, from continuing operations. Excluding lower of cost or market (LCM) adjustment, earnings totaled $1.3Bil, or $2.80 per share, and EBITDA was $2.2Bil. $LYB experienced a transitional period during which markets rebalanced following the decline in supply & price of crude oil in 2Q15.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)